Home Tags COVID19

Tag: COVID19

Lilly scores FDA emergency authorization for Olumiant in COVID-19, its 2nd...

While the list of authorized medicines to treat COVID-19 remains quite short, with a new nod this week, Eli Lilly stands alone in having two therapeutic offerings. Lilly’s...

Airlines rally cold-chain supplies to ship Pfizer, Moderna’s frigid COVID-19 shots

Positive data on Pfizer and Moderna's mRNA vaccine candidates have been tempered in recent weeks by concerns over shipping hurdles for the shots, both of...

Digital innovation and learning during COVID-19

The COVID-19 pandemic has imposed huge economic, social and human costs on the British, and many other societies, but it has also had a...

Generics players join pledge to rapidly scale access to COVID-19 drugs....

As dozens of drugmakers work to create new or repurposed therapies for COVID-19, developing nations worry they will be last in line for supply...

Fierce Pharma Politics—Biden puts COVID-19 transition task force on the job

Welcome to the Fierce Pharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate.  Two days...

Eliquis partners BMS and Pfizer join the pharma crowd urging doctor...

Pfizer and Bristol Myers Squibb are the latest drugmakers to join the swell of campaigns promoting doctor visits during the pandemic. Focused on three health...

COVID-19 fighter remdesivir racks up $873M as Gilead plays defense on...

Gilead Sciences started charging for remdesivir in July. Given its status then as the only drug authorized for COVID-19 in the U.S., industry watchers...

Merck, Pfizer pneumonia vaccines running low in EU as researchers fight...

As COVID-19 continues to rage worldwide, health authorities worry that a perfect storm of the novel coronavirus, pneumonia and seasonal flu could overtake hospital...

Pfizer, Moderna COVID-19 vaccines could reach all Americans by June—if politics...

Moncef Slaoui, co-leader of the U.S. government’s Operation Warp Speed effort, is so confident that Moderna’s and Pfizer’s mRNA vaccines to prevent COVID-19 will...

Pfizer could haul in $3.5B in 2021 from COVID-19 vaccine: analyst

Among the ever-growing collection of biopharma companies developing COVID-19 vaccines, Pfizer is emerging as a clear frontrunner—even after CEO Albert Bourla vowed not to...
0FansLike
68,639FollowersFollow
75,100SubscribersSubscribe

EDITOR PICKS